Gustav Steinhoff

Thoratec left ventricular assist device for bridging to recovery in fulminant acute myocarditis.

Absence of PERV specific humoral immune response in baboons after transplantation of porcine cells or organs.

[Cardiac tissue engineering].

Autologous bone-marrow stem-cell transplantation for myocardial regeneration.

Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice.

Mechanical and structural properties of a novel hybrid heart valve scaffold for tissue engineering.

Biomatrix/polymer composite material for heart valve tissue engineering.

Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice.

Rat cytomegalovirus and Listeria monocytogenes infection enhance chronic rejection after allogenic rat lung transplantation.

Evaluation of coated oxygenators in cardiopulmonary-bypass systems and their impact on neurocognitive function.

[The regenerating heart -- hope for children with congenital heart defects].

Importance of endothelial nitric oxide synthase for the hypothermic protection of lungs against ischemia-reperfusion injury.

Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells.

Stem cell therapy for ischemic heart disease: beginning or end of the road?

Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation.

Pericardial suction blood separation attenuates inflammatory response and hemolysis after cardiopulmonary bypass.

Effects of poly-2-methoxyethylacrylate (PMEA)-coating on CPB circuits.

When less is more: go slowly when repopulating a decellularized valve in vivo!

Ischemic acidosis causes apoptosis in coronary endothelial cells through activation of caspase-12.

Minimizing cardiopulmonary bypass attenuates myocardial damage after cardiac surgery.

Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.

Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.

Prevention of lung allograft rejection by combined treatment with adhesion molecule antibodies and cyclosporine.

Importance of bicarbonate transport for ischaemia-induced apoptosis of coronary endothelial cells.

Endothelial NOS is required for SDF-1alpha/CXCR4-mediated peripheral endothelial adhesion of c-kit+ bone marrow stem cells.

Safety of intramyocardial stem cell therapy for the ischemic myocardium: results of the Rostock trial after 5-year follow-up.

Calcium phosphate surfaces promote osteogenic differentiation of mesenchymal stem cells.

Ventricular septal dissection after patch repair of an infarct-related ventricular septal rupture.

Aortic valve endocarditis due to abiotrophia defectiva: a rare etiology.

Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting.

Enhanced thoracic gene delivery by magnetic nanobead-mediated vector.

Thrombocytopenia after aortic valve replacement with the Freedom Solo stentless bioprosthesis.

Open heart surgery for a very-low-weight (660 g) premature infant.

Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion.

Mesenchymal stem cells and cardiac repair.

Regenerative Medicine--not just one step away.

Current status of intramyocardial bone marrow stem cell transplantation.

eComment: left ventricular catheterization for pressure-volume loop measurements in small laboratory animals.

eComment: Freedom Solo stentless aortic bioprosthesis and postoperative thrombocytopenia--interpretation of available data and clinical consequences for surgeons.

Images in cardiovascular medicine. Local erosions of a bioprosthetic aortic valve cusp caused by towering ring suture knots too close to the valve.

Polyamidoamine dendrimers with a modified Pentaerythritol core having high efficiency and low cytotoxicity as gene carriers.

Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy.

Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.

Localized SDF-1alpha gene release mediated by collagen substrate induces CD117 stem cells homing.

Localized and sustained SDF-1 gene release mediated by fibronectin films: A potential method for recruiting stem cells.

Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.

Papillary fibroelastoma of the aortic wall with partial occlusion of the right coronary ostium.

Pressure-volume loops: feasible for the evaluation of right ventricular function in an experimental model of acute pulmonary regurgitation?

Retraction: Mesenchymal Stem Cells: Are They Suitable for Systemic Injection? An In Vitro Study.

Autologous umbilical cord blood mononuclear cell transplantation preserves right ventricular function in a novel model of chronic right ventricular volume overload.

A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart.

Laser printing of skin cells and human stem cells.

[Autologous stem cell therapy with surgical myocardial revascularization - The Rostock University experience].

Stem cell-mediated neovascularization in heart repair.

Hypoxic/normoxic preconditioning increases endothelial differentiation potential of human bone marrow CD133+ cells.

Acute and chronic response of the right ventricle to surgically induced pressure and volume overload--an analysis of pressure-volume relations.

Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.

[Surgical intramyocardial stem cell therapy for chronic ischemic heart failure].

Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients.

Transvalvular intramyocardial bone marrow stem cell transplantation in combination with videoscopic mitral valve repair.

Autologous valve replacement-CD133+ stem cell-plus-fibrin composite-based sprayed cell seeding for intraoperative heart valve tissue engineering.

Identification of noncytotoxic and IL-10-producing CD8+AT2R+ T cell population in response to ischemic heart injury.

Papillary fibroelastoma of the left heart with multiple origins?

Mechanical integrin stress and magnetic forces induce biological responses in mesenchymal stem cells which depend on environmental factors.

Animal models of cardiac disease and stem cell therapy.

Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration.

Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.

Mesenchymal stem cells restore lung function by recruiting resident and nonresident proteins.

Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.

Early stenotic prosthesis failure after implantation of a stentless porcine aortic valve prosthesis.

HMGB-1 induces c-kit+ cell microvascular rolling and adhesion via both toll-like receptor-2 and toll-like receptor-4 of endothelial cells.

10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice.

Culture-negative infective endocarditis of the aortic valve due to Aerococcus urinae: a rare aetiology.

Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration.

Magnetic targeting strategies in gene delivery.

Transient ischaemic attack due to the lead of an implantable defibrillator in the left heart.

Erythropoietin attenuates the sequels of ischaemic spinal cord injury with enhanced recruitment of CD34+ cells in mice.

In-Hospital Outcome of Patients with Severe Mitral Valve Regurgitation Classified as Inoperable and Treated with the MitraClip(®) Device.

Bilateral tension pneumothoraces leading to cardiac arrest after coronary artery bypass surgery.

Uncomplicated prior right ventricular perforation due to a pacemaker lead - an incidental finding during coronary artery bypass surgery.

Congenital quadricuspid aortic valve: a rare valvular pathology leading to aortic valve insufficiency.

Update on cardiac stem cell therapy in heart failure.

The regenerative potential of angiotensin AT2 receptor in cardiac repair.

Comparing microvascular alterations during minimal extracorporeal circulation and conventional cardiopulmonary bypass in coronary artery bypass graft surgery: a prospective, randomized study.

Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial.

Targeted delivery of human VEGF gene via complexes of magnetic nanoparticle-adenoviral vectors enhanced cardiac regeneration.

Analyzing migratory properties of human CD133(+) stem cells in vivo after intraoperative sternal bone marrow isolation.

Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction.

Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease.

CD133-Positive Cells for Cardiac Stem Cell Therapy: Current Status and Outlook.

Spray- and laser-assisted biomaterial processing for fast and efficient autologous cell-plus-matrix tissue engineering.

Asymptomatic blood cyst of the papillary muscle in an adult undergoing coronary bypass surgery.

The road from systems biology to systems medicine.

Non-viral gene delivery methods.

Dental follicle progenitor cells responses to Porphyromonas gingivalis LPS.

Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles.

Surgical double valve replacement after transcatheter aortic valve implantation and interventional mitral valve repair.

Transplantation of preconditioned bone marrow mononuclear cells by AT2R stimulation improves infarcted heart function via enhanced cardiac mobilization of implanted cells.

Improved transfection in human mesenchymal stem cells: effective intracellular release of pDNA by magnetic polyplexes.

Re-growth of the adult heart by stem cells?

Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium.

Surgical revision after percutaneous mitral valve repair by edge-to-edge device: when the strategy fails in the highest risk surgical population.

Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair.

White paper on how to go forward with cell-based advanced therapies in Europe.

Impact of closed minimal extracorporeal circulation on microvascular tissue perfusion during surgical aortic valve replacement: intravital imaging in a prospective randomized study.

Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105(+) hMSCs.

Impact of short-term liquid storage on human CD133(+) stem cells.

Programming and isolation of highly pure physiologically and pharmacologically functional sinus-nodal bodies from pluripotent stem cells.

Awake extracorporeal membrane oxygenation (ECMO) as bridge to recovery after left main coronary artery occlusion: a promising concept of haemodynamic support in cardiogenic shock.

Selective Migration of Subpopulations of Bone Marrow Cells along an SDF-1α and ATP Gradient.

Defining optimized properties of modified mRNA to enhance virus- and DNA- independent protein expression in adult stem cells and fibroblasts.

Mesenchymal stem cell therapy in nonhematopoietic diseases.

(124)I-PET Assessment of Human Sodium Iodide Symporter Reporter Gene Activity for Highly Sensitive In Vivo Monitoring of Teratoma Formation in Mice.

The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function.

Do oral bacteria alter the regenerative potential of stem cells? A concise review.

Arthralgia and blood culture-negative endocarditis in middle Age Men suggest tropheryma whipplei infection: report of two cases and review of the literature.

Exploiting AT2R to Improve CD117 Stem Cell Function In Vitro and In Vivo--Perspectives for Cardiac Stem Cell Therapy.

Gap junctional shuttling of miRNA--A novel pathway of intercellular gene regulation and its prospects in clinical application.

Streptococcus bovis infectious endocarditis and occult gastrointestinal neoplasia: experience with 25 consecutive patients treated surgically.

Mobilization of Bone Marrow-Derived Endothelial Progenitor Cells following Finnish Sauna: A Pilot Study.

TRAPLINE: a standardized and automated pipeline for RNA sequencing data analysis, evaluation and annotation.

Non-viral magnetic engineering of endothelial cells with microRNA and plasmid-DNA-An optimized targeting approach.

Applying 3D-FRAP microscopy to analyse gap junction-dependent shuttling of small antisense RNAs between cardiomyocytes.

Magnet-Bead Based MicroRNA Delivery System to Modify CD133(+) Stem Cells.

GMP-conformant on-site manufacturing of a CD133(+) stem cell product for cardiovascular regeneration.

Conventional Surgery For Early and Late Symptomatic Mitral Valve Stenosis After MitraClip(®) Intervention: An Institutional Experience With Four Consecutive Patients.

Clinical outcomes of conventional surgery versus MitraClip® therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience.

Therapeutic progenitor cell application for tissue regeneration: Analyzing the impact of toll-like receptor signaling on c-kit(+) cell migration following ischemia-reperfusion injury in vivo.

Stem cell registry programme for patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting: what benefits does it derive?

Intramyocardial fate and effect of iron nanoparticles co-injected with MACS(®) purified stem cell products.

Cardiac Cell Therapies for the Treatment of Acute Myocardial Infarction: A Meta-Analysis from Mouse Studies.

Data on the fate of MACS® MicroBeads intramyocardially co-injected with stem cell products.

Cardiac Mesenchymal Stem Cells Proliferate Early in the Ischemic Heart.

Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart.